Interferon beta-1b
Interferon beta-1b (pronounced as in-ter-FEER-on BAY-ta) is a type of protein and biopharmaceutical that is used to treat and manage Multiple Sclerosis, a chronic disease that affects the nervous system.
Etymology
The term "Interferon beta-1b" is derived from its biological function. "Interferon" refers to a group of signaling proteins that "interfere" with viral infections. "Beta" is a subtype of interferon that is involved in the regulation of the immune system. The "1b" denotes the specific variant of interferon beta.
Usage
Interferon beta-1b is used in the treatment of relapsing forms of multiple sclerosis. It is not a cure for MS but it is designed to decrease the frequency of relapse symptoms.
Mechanism of Action
Interferon beta-1b works by decreasing the immune system's harmful response to the body's own cells. It also reduces the ability of immune cells to cross the blood-brain barrier, which can cause inflammation and damage in the nervous system.
Related Terms
- Interferon
- Multiple Sclerosis
- Protein
- Biopharmaceutical
- Blood-brain barrier
- Nervous system
- Immune system
See Also
External links
- Medical encyclopedia article on Interferon beta-1b
- Wikipedia's article - Interferon beta-1b
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski